Evolocumab is a human monoclonal antibody that inhibits PCSK9, preventing its interaction with the LDL receptor. It is widely used in preclinical and clinical research for studying hypercholesterolemia and atherosclerotic cardiovascular disease, including in vitro binding assays and in vivo models of lipid metabolism.
Concentration:
140 mg/mL
Molecular Weight:
144 kDa
Purity:
98.30% (May vary between batches)
CAS Number:
[1256937-27-5]
Target:
NF-kappaB,TLR,Serine Protease,Others,LDLR
* VAT and and shipping costs not included. Errors and price changes excepted